• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ADVANTAGE SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ADVANTAGE SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number 850-200
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Incontinence (1928); Inflammation (1932); Pain (1994); Abnormal Vaginal Discharge (2123); Anxiety (2328); Depression (2361); Dyspareunia (4505); Insufficient Information (4580)
Event Date 01/14/2002
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an advantage sling was implanted into the patient on (b)(6) 2001.The patient experienced complications and nonsurgical treatment.Patient symptoms include: eep (erosion/extrusion/protrusion of the mesh); back pain; vaginal pain; pelvic pain; groin pain; thigh pain; painful intercourse; inability to have intercourse; offensive vaginal discharge; recurrent incontinence; damage; psychiatric injury nonsurgical treatments: on (b)(6) 2002 the patient commenced pain medication: panadeine forte to reduce pain.Treatment duration: 20.On (b)(6) 2004 the patient commenced pain medication: vioxx to reduce inflammation.Treatment duration: 4 years.On (b)(6) 2005 the patient commenced psychological medication: zoloft/now duloxetine for the treatment of: depression/anxiety.Treatment duration: 16 years.On (b)(6) 2007 the patient commenced injections (not associated with surgical treatment): steroid injection to reduce inflammation and pain in lower back.Treatment duration: 4.On (b)(6) 2018 the patient commenced topical treatment (including oestrogen cream): estradiol gel for vaginal atrophy and dryness.Treatment duration: 2 years.
 
Manufacturer Narrative
(b)(6).The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.The upn provided was chosen as a representative upn to capture the implanted device.The complainant indicated that the device is not available for return; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANTAGE SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key12930545
MDR Text Key286873937
Report Number3005099803-2021-07303
Device Sequence Number1
Product Code OTN
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K020110
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number850-200
Device Catalogue Number850-200
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/10/2021
Initial Date FDA Received12/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age43 YR
Patient SexFemale
Patient Weight70 KG
-
-